INSIGHTS ON DRUG DEVELOPMENT

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• IP Considerations In Drug Development For Biotech Companies

  Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.

• White Paper: Spray Drying Biologics: An Alternative To Freeze Drying

  Explore how innovative drying technologies can enhance the stability and efficacy of biologics, ensuring successful outcomes in this rapidly growing sector of the pharmaceutical industry.

• Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success

  By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

• Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies

  7/15/2026

  In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.

• Integrated Stability Workflows That Reduce Manual Data Handling

  5/28/2026

  Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.

• Amorphous Solids: Implications For Solubility And Stability

  5/6/2026

  Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.

• LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting

  7/29/2025

  Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.

• Futurizing Healthcare By Localizing The Life Sciences

  12/12/2024

  Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.